# MSC Income Fund, Inc.: overview MSIF · NYSE · CIK 1535778 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/msif.md) · [Financials](/companies/msif/financials.md) · [Filings](/companies/msif/filings.md) · [Insiders](/companies/msif/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.32](/filings/0001535778-25-000148.md) | not reported | [0.35](/filings/0001535778-26-000048.md) | [0.35](/filings/0001535778-25-000126.md) | [0.35](/filings/0001535778-25-000148.md) | not reported | [0.35](/filings/0001535778-26-000048.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.67](/filings/0001535778-24-000020.md) | [1.32](/filings/0001535778-25-000073.md) | [1.38](/filings/0001535778-26-000026.md) | [1.34](/filings/0001535778-26-000026.md) | [1.33](/filings/0001535778-26-000026.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/msif/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SANDERS MORRIS HARRIS LLC](/funds/1053994.md) | 2026-06-30 | $26.2m | 2,263,426 | | Added +457,004 | | [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $14.7m | 1,267,910 | | Added +441,264 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $11.6m | 1,006,541 | | Added +209,794 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $10.6m | 915,670 | | Added +241,495 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $9.1m | 783,888 | | Reduced −350,383 | | [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $9.0m | 779,528 | | Added +152,395 | | [North Ground Capital](/funds/2055446.md) | 2026-06-30 | $6.2m | 537,600 | | Added +88,681 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $5.1m | 444,595 | | Reduced −9,997 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $3.7m | 318,804 | | Added +229,487 | | [Cetera Investment Advisers](/funds/1666741.md) | 2026-06-30 | $3.0m | 258,741 | | Reduced −52,816 | ## Recent filings [All 811 filings](/companies/msif/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-08 | 13:35 ET | [8-K](/filings/0001535778-26-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001535778-26-000096 | | 2026-09-01 | 20:24 ET | [8-K](/filings/0001535778-26-000092.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001535778-26-000092 | | 2026-08-07 | 15:44 ET | [10-Q](/filings/0001535778-26-000085.md) | Quarterly report, period 2026-06-30 | 0001535778-26-000085 | | 2026-08-06 | 20:33 ET | [8-K](/filings/0001535778-26-000081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001535778-26-000081 | | 2026-08-06 | 13:41 ET | [8-K](/filings/0001535778-26-000079.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001535778-26-000079 | | 2026-08-05 | 20:26 ET | [8-K](/filings/0001535778-26-000077.md) | 5.07 Shareholder vote results | 0001535778-26-000077 | | 2026-07-09 | 13:39 ET | [8-K](/filings/0001535778-26-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001535778-26-000074 | | 2026-06-30 | 13:32 ET | [8-K](/filings/0001535778-26-000072.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001535778-26-000072 | | 2026-06-11 | 17:09 ET | [8-K](/filings/0001535778-26-000065.md) | 7.01 Regulation FD disclosure | 0001535778-26-000065 | | 2026-05-20 | 12:48 ET | [DEF 14A](/filings/0001535778-26-000061.md) | Proxy statement, period 2026-08-05 | 0001535778-26-000061 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001535778-26-000026.md), filed Feb 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1535778 - Tickers: MSIF - Exchange: NYSE - SIC code: not reported - State of incorporation: not reported - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.